Dan T. Vogl, MD, MSCE is Associate Professor of Medicine in the Division of Hematology and Oncology at the Abramson Cancer Center of the University of Pennsylvania in Philadelphia. Dr. Vogl earned his medical degree from Weill Medical College of Cornell University in New York. He completed his residency in Internal Medicine at Columbia-Presbyterian Medical Center in New York, and a fellowship in Hematology and Oncology at the Hospital of the University of Pennsylvania in Philadelphia. In addition, Dr. Vogl has received a Master of Science in Clinical Epidemiology from the University of Pennsylvania School of Medicine. Dr. Vogl joined Penn’s Myeloma Program in 2006, and since 2015, he has been Medical Director of the Abramson Cancer Center’s Clinical Research Unit, overseeing the work of over 90 research nurses, research coordinators, regulatory coordinators, and biospecimen coordinators, who together manage over 300 active cancer clinical trials. Dr. Vogl’s clinical and translational research focuses on novel therapies for relapsed and refractory multiple myeloma.